UMN Pharma
Latest round
- Series C
Last raised
- Feb 2007
Total raised
- $29M
Investors
- 22
About UMN Pharma
Founded in 2004 and headquartered in Akita-shi, Japan, UMN Pharma develops biotechnology products, particularly vaccines. The company went public in December 2012 by listing its common stocks on the Tokyo Stock Exchange Mothers market, with a valuation set between 1300 and 1600 JPY. The founder's history and prior ventures are not specified.UMN Pharma, Inc. specializes in the development and production of cutting-edge biotechnological products, specifically focusing on innovative vaccine solutions. Their core offerings include a portfolio of vaccines designed to address various infectious diseases, leveraging advanced biotechnology to create gentler yet effective immunization options for patients. These vaccines are engineered to enhance efficacy while minimizing adverse effects, thereby catering to healthcare institutions and public health organizations.UMN Pharma aims to expand its product offerings with new vaccines targeting additional infectious diseases, although specific release dates have not been disclosed. The company is also focused on expanding into new markets beyond Asia, targeting regions where vaccine demand is increasing. The successful public listing on December 11, 2012, facilitated this growth strategy, with financial advisors including Nomura and Mizuho.
Who invested in UMN Pharma
22 investors across 5 rounds
See all investors in UMN Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about UMN Pharma
Who invested in UMN Pharma?
UMN Pharma has 22 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has UMN Pharma raised?
UMN Pharma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did UMN Pharma last raise money?
UMN Pharma's most recent round on record is a Series C, in Feb 2007.
What does UMN Pharma do?
Founded in 2004 and headquartered in Akita-shi, Japan, UMN Pharma develops biotechnology products, particularly vaccines.
Where is UMN Pharma headquartered?
UMN Pharma is headquartered in Akita-shi, Japan.
Which VCs invest in companies like UMN Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at UMN Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like UMN Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.